Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
Stryker Corporation (SYK) is well poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. Meanwhile, improvement in price also buoys optimism.Shares of this currently Zacks Rank #3 (Hold) company have risen 16.4% in the past year compared with the industry’s 1.7% growth. The S&P 500 Index has increased 23.8% in the same time frame.Stryker, with a market capitalization of $112.54 billion, is one of the world’s largest medical device companies op ...